HDAC-dependent regulation and functional relevance of WT1 during replicative stress
HDAC-dependent regulation and functional relevance of WT1 during replicative stress
批准号:
286787523
负责人:
Professor Dr. Oliver Holger Krämer
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2018-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project aims to analyze molecular mechanisms controlling the transcription factor WT1 as well as the biological functions of WT1 in primary and permanent leukemic cells undergoing replicative stress and DNA damage. We focus on the regulation of WT1 by epigenetic modifiers belonging to the group of class I histone deacetylases (HDACs). Inhibitors of these enzymes induce the proteasomal degradation of WT1 (involving the E2 ubiquitin conjugase UBCH8) and a loss of WT1 mRNA expression. We want to define, which class I HDACs control the expression of the WT1 gene and of the UBE2L6 gene encoding UBCH8. Furthermore, we want to identify targets of WT1 that affect apoptosis upon disturbed DNA replication. Additionally we will test whether WT1 directly controls replicative stress signaling, the DNA replication checkpoint, and DNA damage. Moreover, we will analyze the relevance of the checkpoint kinases ATM, ATR, and CHK1/CHK2 in cells with inactivated class I HDACs combined with replicative stress. We also aim to understand the HDAC-dependent regulation and the biological relevance of the pro-apoptotic factor NOXA for the survival of leukemic cells undergoing replication arrest and a loss of WT1. We have a biochemical and molecular approach. We deplete the cellular dNTP pool with hydroxyurea, we use the HDACi MS-275 that specifically block the class I HDACs HDAC1, -2, and -3, and we eliminate proteins of interest genetically. The methods we employ are Western blot to detect protein expression and phosphorylation, quantitative real-time PCR, confocal microscopy, quantitative proteomics, i-POND, DNA fiber assay, flow cytometry assessing cell vitality, CRSPR-Cas9 and RNAi.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analysis of molecular mechanisms that are regulated through HDAC6and heat shock proteins in leukemic cells
-
批准号:427404172
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Professor Dr. Oliver Holger Krämer
-
依托单位:
Synthesis and pharmacological characterization of novel and selective FLT3 inhibitors
-
批准号:351954221
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Professor Dr. Oliver Holger Krämer
-
依托单位:
Regulation of Replicative Stress Signaling by Deacetylation and Dephosphorylation
-
批准号:325554574
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Professor Dr. Oliver Holger Krämer
-
依托单位:
Synthesis and pharmacological characterization of novel histone deacetylase 6 inhibitors
-
批准号:251120574
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Professor Dr. Oliver Holger Krämer
-
依托单位:
Synthesis and pharmacology of novel inhibitors of histone deacetylases and of proteolysis targeting chimeras (PROTACs) for mutant FMS-like tyrosine kinase-3
-
批准号:495271833
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Oliver Holger Krämer
-
依托单位:
Analysis of how the epigenetic modifiers HDAC1, HDAC2, and HDAC3 control cytotoxicity and the induction of DNA damage in cancer cells upon DNA replication stress
-
批准号:496927074
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Oliver Holger Krämer
-
依托单位:
Molecular Design, Synthesis, and Pharmacology of Targeted Protein Degraders for the Checkpoint Kinase ATR
-
批准号:528202295
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Oliver Holger Krämer
-
依托单位:
Molecular Design, Synthesis, and Pharmacology of Novel and Selective Histone Deacetylae 10 (HDAC10) Inhibitors
-
批准号:469954457
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Oliver Holger Krämer
-
依托单位:
Delineating the novel HDAC3-SIAH2 signaling node and its impact on oncogenic JAK2 in leukemic cells
-
批准号:445785155
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Oliver Holger Krämer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
-
批准号:82371660
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:魏喆
-
依托单位:
当归芍药散基于双向调控Ras/cAMP-dependent PKA自噬通路的“酸甘化阴、辛甘化阳”的药性基础
-
批准号:81973497
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:刘四军
-
依托单位:
CDK5调节羊驼黑色素生成的作用研究
-
批准号:31201868
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:范瑞文
-
依托单位:
蒺藜苜蓿细胞周期蛋白依赖性激酶(cyclin-dependent kinase)对根瘤发育的功能研究
-
批准号:31100871
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2011
-
负责人:何恒斌
-
依托单位:
铁磁、半金属-超导异质结中电子输运的理论研究
-
批准号:60971053
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2009
-
负责人:周世平
-
依托单位:
Riesz乘积和树上的分枝测度的重分形分析
-
批准号:10826054
-
项目类别:数学天元基金项目
-
资助金额:3.0万元
-
批准年份:2008
-
负责人:章雄鹰
-
依托单位:
CaMK II信号转导通路参与前扣带回皮质调节IBS大鼠的内脏痛觉
-
批准号:30800512
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:曹芝君
-
依托单位:
Posphoinositide-dependent kinase-1在肿瘤细胞趋化运动和转移中的作用机制
-
批准号:30772529
-
项目类别:面上项目
-
资助金额:29.0万元
-
批准年份:2007
-
负责人:张宁
-
依托单位: